Michael Watt
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Estimation of Health Utility Values for Eosinophilic Granulomatosis With Polyangiitis.
Journal: PharmacoEconomics - open
Published: July 16, 2025
Barriers and facilitators to practitioner prescribing and patient adoption of anti-inflammatory maintenance and reliever therapy (MART) for adult asthma: a qualitative study.
Journal: BMC primary care
Published: March 19, 2025
Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication.
Journal: Immunotherapy
Published: February 11, 2025
XALOC-1: Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic Asthma.
Journal: Chest
Published: November 13, 2024
Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study.
Journal: Journal of health economics and outcomes research
Published: May 01, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: April 17, 2024
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.
Journal: The European respiratory journal
Published: September 08, 2023
Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site.
Journal: ERJ open research
Published: December 08, 2022
Safety climate and workplace violence prevention in state-run residential addiction treatment centers.
Journal: Work (Reading, Mass.)
Published: May 29, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026